المؤلفون: Sam Z. Bacharach, Michael G. Tordoff, Amber L. Alhadeff

المصدر: Cellular and Molecular Gastroenterology and Hepatology, Vol 16, Iss 2, Pp 189-199 (2023)

مصطلحات موضوعية: Hepatic Portal Vein, Food Intake, Reward, Nutrient Sensing, Diseases of the digestive system. Gastroenterology, RC799-869

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352345X23000644Test; https://doaj.org/toc/2352-345XTest

الوصول الحر: https://doaj.org/article/c4a1ec16d4f548b5874c071a2ef7eb48Test

المؤلفون: Ãœtebey, AyÅŸe Rüksan, Ufuk, Furkan, Aykota, Muhammed RaÅŸid

مصطلحات موضوعية: Cirrhosis, congenital, diagnosis, liver, portal hypertension, portal vein, abdominal bleeding, abernethy malformation, adult, benign liver tumor, case report, clinical article, computer assisted tomography, congenital malformation, female, follow up, glucose transport, heart failure, hepatic encephalopathy, hepatic portal vein, hepatopulmonary syndrome, human, hyperinsulinism, hypoglycemia, inferior cava vein, Letter, osteoporosis, pathophysiology, pulmonary hypertension, systemic circulation

العلاقة: Diagnostic and Interventional Radiology; DiÄŸer; https://doi.org/10.5152/dir.2022.211146Test; https://hdl.handle.net/11499/51319Test; 29; 410; 411; 2-s2.0-85151107641; WOS:001038761200014

الإتاحة: https://doi.org/10.5152/dir.2022.211146Test
https://hdl.handle.net/11499/51319Test

المؤلفون: Xiaofang Du, Rong Zou, Kun Du, Dabing Huang, Chunguang Miao, Bensheng Qiu, Weiping Ding, Chengpan Li

مصطلحات موضوعية: Medicine, Genetics, Pharmacology, Developmental Biology, Cancer, Virology, Chemical Sciences not elsewhere classified, replicated intrahepatic angiogenesis, hepatic cell functions, modeling colorectal cancer, cancer cells migrate, portal vein microthrombus, hepatic lobule chip, disordered hepatic plates, colorectal cancer cells, understanding pvtt evolution, thickened blood vessels, hepatic portal vein, common malignant tumors, chip pvmt model, colorectal cancer, portal vein, hepatic cells, hepatic plates, microfluidic chip, valuable reference, study provides, pvtt therapy, pvtt ), promising method

العلاقة: https://figshare.com/articles/journal_contribution/Modeling_Colorectal_Cancer-Induced_Liver_Portal_Vein_Microthrombus_on_a_Hepatic_Lobule_Chip/24700824Test

الإتاحة: https://doi.org/10.1021/acsami.3c14417.s001Test
https://figshare.com/articles/journal_contribution/Modeling_Colorectal_Cancer-Induced_Liver_Portal_Vein_Microthrombus_on_a_Hepatic_Lobule_Chip/24700824Test

المؤلفون: Ojha, Khagendra, Yadav, Prasun, Timilsina, Binaya, Mallik, Vipul Bhushan, Khatiwada, Sagar, Belbase, Narayan Prasad

المصدر: Journal of College of Medical Sciences-Nepal; Vol. 19 No. 4 (2023): Oct-Dec; 505-508 ; 2091-0673 ; 2091-0657

مصطلحات موضوعية: cavernous transformation, extra hepatic portal vein obstruction, leino-adrenal shunt, linton’s shunt, surgical decompression

وصف الملف: application/pdf

العلاقة: https://www.nepjol.info/index.php/JCMSN/article/view/56905/45956Test; https://www.nepjol.info/index.php/JCMSN/article/view/56905Test

الإتاحة: https://www.nepjol.info/index.php/JCMSN/article/view/56905Test

المؤلفون: I. A. Dzhanyan, M. N. Khagazheeva, V. V. Breder, D. I. Yudin, I. V. Pogrebnyakov, A. E. Kuzminov, E. Yu. Antonova, N. M. Starostin, И. А. Джанян, М. Н. Хагажеева, В. В. Бредер, Д. И. Юдин, И. В. Погребняков, А. Е. Кузьминов, Е. Ю. Антонова, Н. М. Старостин

المصدر: Meditsinskiy sovet = Medical Council; № 11 (2023); 10-17 ; Медицинский Совет; № 11 (2023); 10-17 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: симптоматическая терапия, hepatic portal vein thrombosis, multikinase inhibitors, sorafenib, cirrhosis decompensation, first-line therapy, symptomatic therapy, тромбоз воротной вены, мультикиназные ингибиторы, сорафениб, декомпенсация цирроза, первая линия терапии

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/7663/6797Test; Бредер В.В., Базин И.С., Балахнин П.В., Виршке Э.Р., Косырев В.Ю., Ледин Е.В. и др. Практические рекомендации по лекарственному лечению больных злокачественными опухолями печени и желчевыводящей системы. Злокачественные опухоли. 2022;12(3s2-1):467–529. https://doi.org/10.18027/2224-5057-2022-12-3s2-467-529Test.; Каприн А.Д., Старинский В.В., Петрова Г.В. (ред.). Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.: МНИОИ; 2018. 250 с. Режим доступа: https://glavonco.ru/upload/pages/cancer-register/statistika_zabol_2017.pdfTest.; Cheng A.L., Qin S., Ikeda M., Galle P.R., Ducreux M., Kim T.Y. et al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022;76(4):862–873. https://doi.org/10.1016/j.jhep.2021.11.030Test.; Morse M.A., Sun W., Kim R., He A.R., Abada P.B., Mynderse M., Finn R.S. The Role of Angiogenesis in Hepatocellular Carcinoma. Clin Cancer Res. 2019;25(3):912–920. https://doi.org/10.1158/1078-0432.CCR-18-1254Test.; Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492Test.; Hegde P.S., Wallin J.J., Mancao C. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics. Semin Cancer Biol. 2018;52(Pt 2):117–124. https://doi.org/10.1016/j.semcancer.2017.12.002Test.; Lu L.C., Hsu C., Shao Y.Y., Chao Y., Yen C.J., Shih I.L. et al. Differential OrganSpecific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Liver Cancer. 2019;8(6):480–490. https://doi.org/10.1159/000501275Test.; Kim H.S., Hong J.Y., Cheon J., Kim I., Kim C.G., Kang B. et al. Different organspecific response to nivolumab to determine the survival outcome of patients with advanced hepatocellular carcinoma (aHCC). J Clin Oncol. 2020;38(Suppl. 15):4584–4584. https://doi.org/10.1200/JCO.2020.38.15_suppl.4584Test.; Yoong K.F., McNab G., Hübscher S.G., Adams D.H. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol. 1998;160(8):3978–3988. https://doi.org/10.4049/jimmunol.160.8.3978Test.; Lee M.S., Ryoo B.Y., Hsu C.H., Numata K., Stein S., Verret W. et al. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Lancet Oncol. 2020;21(6):808–820. https://doi.org/10.1016/S1470-2045Test(20)30156-X.; Fulgenzi C.A.M., Cheon J., D’Alessio A., Nishida N., Ang C., Marron T.U. et al. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. Eur J Cancer. 2022;175:204–213. https://doi.org/10.1016/j.ejca.2022.08.024Test.; Zhu A.X., Duda D.G., Sahani D.V., Jain R.K. HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol. 2011;8(5):292–301. https://doi.org/10.1038/nrclinonc.2011.30Test.; Motz G.T., Santoro S.P., Wang L.P., Garrabrant T., Lastra R.R., Hagemann I.S., et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat Med. 2014;20(6):607–615. https://doi.org/10.1038/nm.3541Test.; Wallin J.J., Bendell J.C., Funke R., Sznol M., Korski K., Jones S. et al. Atezolizumab in combination with bevacizumab enhances antigenspecific T-cell migration in metastatic renal cell carcinoma. Nat Commun. 2016;7:12624. https://doi.org/10.1038/ncomms12624Test.; Chen D.S., Hurwitz H. Combinations of Bevacizumab With Cancer Immunotherapy. Cancer J. 2018;24(4):193–204. https://doi.org/10.1097/PPO.0000000000000327Test.; Herbst R.S., Soria J.C., Kowanetz M., Fine G.D., Hamid O., Gordon M.S. et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature. 2014;515(7528):563–567. https://doi.org/10.1038/nature14011Test.; Finn R.S., Bentley G., Britten C.D., Amado R., Busuttil R.W. Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model. Liver Int. 2009;29(2):284–290. https://doi.org/10.1111/j.1478-3231.2008.01762.xTest.; Boige V., Malka D., Bourredjem A., Dromain C., Baey C., Jacques N. et al. Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma. Oncologist. 2012;17(8):1063–1072. https://doi.org/10.1634/theoncologist.2011-0465Test.; Siegel A.B., Cohen E.I., Ocean A., Lehrer D., Goldenberg A., Knox J.J. et al. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008;26(18):2992–2928. https://doi.org/10.1200/JCO.2007.15.9947Test.; Thomas M.B., Garrett-Mayer E., Anis M., Anderton K., Bentz T., Edwards A. et al. A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma. Oncology. 2018;94(6):329–339. https://doi.org/10.1159/000485384Test.; Finn R.S., Qin S., Ikeda M., Galle P.R., Ducreux M., Kim T.Y. et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382(20):1894–1905. https://doi.org/10.1056/NEJMoa1915745Test.; Finn R.S., Qin S., Ikeda M., Galle P.R., Ducreux M., Kim T.Y. et al. IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC). J Clin Oncol. 2021;39(Suppl. 3):267–267. https://doi.org/10.1200/JCO.2021.39.3_suppl.267Test.; De Franchis R., Bosch J., Garcia-Tsao G., Reiberger T., Ripoll C. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974. https://doi.org/10.1016/j.jhep.2021.12.022Test.; https://www.med-sovet.pro/jour/article/view/7663Test

الإتاحة: https://doi.org/10.21518/ms2023-177Test
https://doi.org/10.18027/2224-5057-2022-12-3s2-467-529Test
https://doi.org/10.1016/j.jhep.2021.11.030Test
https://doi.org/10.1158/1078-0432.CCR-18-1254Test
https://doi.org/10.3322/caac.21492Test
https://doi.org/10.1016/j.semcancer.2017.12.002Test
https://doi.org/10.1159/000501275Test
https://doi.org/10.1200/JCO.2020.38.15_suppl.4584Test
https://doi.org/10.4049/jimmunol.160.8.3978Test
https://doi.org/10.1016/S1470-2045Test(20)30156-X

المؤلفون: Dhanju, Avtar Singh, Narang, Nisha, Singh, Rajdeep, Kaur, Harsimran, Singh, Harkanwarpreet

المصدر: International Journal of Advances in Medicine; Vol. 10 No. 6 (2023): June 2023; 482-484 ; 2349-3933 ; 2349-3925

مصطلحات موضوعية: Extra-hepatic portal vein obstruction, Portal cholangiopathy, Portal cavernoma, Portal vein thrombosis

وصف الملف: application/pdf

العلاقة: https://www.ijmedicine.com/index.php/ijam/article/view/3824/2568Test; https://www.ijmedicine.com/index.php/ijam/article/view/3824Test

الإتاحة: https://doi.org/10.18203/2349-3933.ijam20231458Test
https://www.ijmedicine.com/index.php/ijam/article/view/3824Test

المؤلفون: Lianfu Ji, Zhaoming Ji, Dandan Xiang, Yuming Qin, Shiwei Yang

المصدر: Frontiers in Pediatrics, Vol 10 (2022)

مصطلحات موضوعية: abernethy malformation, hepatic portal vein system, hepatopulmonary syndrome, splenic arteriography, inferior vena cava balloon occlusion test, Pediatrics, RJ1-570

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fped.2022.856611/fullTest; https://doaj.org/toc/2296-2360Test

الوصول الحر: https://doaj.org/article/c8af0df200ad42f28e2573a3a7f0302aTest

المؤلفون: Lichao Deng, Deyan Liu, Peng Jia, Limei Yan

المصدر: Asian Journal of Surgery, Vol 45, Iss 9, Pp 1803-1804 (2022)

مصطلحات موضوعية: Anatomy, Hand as Foot, Hepatic portal vein branch, Teaching method, Surgery, RD1-811

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S1015958422003633Test; https://doaj.org/toc/1015-9584Test

الوصول الحر: https://doaj.org/article/cbfd19da6eb04aaf97e1e68c99168e3eTest

المؤلفون: Archana George Vallonthaiel, Vandana Baloda, Lavleen Singh, Rajni Yadav, Ragini Kilambi, Sudha Battu, Vishnubhatla Sreenivas, Sujoy Pal, Subrat K Acharya, Siddhartha DattaGupta, Shalimar, Prasenjit Das

المصدر: Indian Journal of Pathology and Microbiology, Vol 64, Iss 5, Pp 127-135 (2021)

مصطلحات موضوعية: extra-hepatic portal vein obstruction, histology, noncirrhotic portal fibrosis, portal hypertension, portal vein, Pathology, RB1-214, Microbiology, QR1-502

وصف الملف: electronic resource

العلاقة: http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2021;volume=64;issue=5;spage=127;epage=135;aulast=VallonthaielTest; https://doaj.org/toc/0377-4929Test

الوصول الحر: https://doaj.org/article/f6702fe8a3284562a29b13482babbdb3Test

المؤلفون: Andrew Johnson, Gianluca Polese, Max Johnson, William Winlow

المساهمون: Johnson, Andrew, Polese, Gianluca, Johnson, Max, Winlow, William

مصطلحات موضوعية: human serum albumin, COVID-19 vulnerabilities, fluid therapy, albumin binding deficiency, lymphatic nutrient pump, colloid pressure, interstitial spaces, albumin infusion, hepatic portal vein

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001178482800001; volume:2; issue:10; firstpage:1379; lastpage:1395; numberofpages:17; journal:COVID; https://hdl.handle.net/11588/904349Test

الإتاحة: https://doi.org/10.3390/covid2100099Test
https://hdl.handle.net/11588/904349Test